Tolurindo 40 mg/1,5 mg tablete s prilagođenim oslobađanjem
| Name | Tolurindo 40 mg/1,5 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-018945571 |
| Active Substance | telmisartan indapamid |
| Composition | jedna tableta s prilagođenim oslobađanjem sadrži 40 mg telmisartana i 1,5 mg indapamida |
| Pharmaceutical Form | Tableta s prilagođenim oslobađanjem |
| Manufacturer | TAD Pharma Gmbh, Cuxhaven, Njemačka Krka d.d. Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.10.2024 |
| MA Period of Validity | 17.10.2029 |
| Classification Number | UP/I-530-09/23-01/234 |
| Registration Number | 381-12-01/70-24-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DA07 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
